Literature DB >> 14766129

Vancomycin does not benefit persistently febrile neutropenic people with cancer.

James C Wade1, Axel Glasmacher.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14766129     DOI: 10.1016/j.ctrv.2003.11.008

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN: 0305-7372            Impact factor:   12.111


× No keyword cloud information.
  1 in total

Review 1.  Empirical antibiotics targeting gram-positive bacteria for the treatment of febrile neutropenic patients with cancer.

Authors:  Ofrat Beyar-Katz; Yaakov Dickstein; Sara Borok; Liat Vidal; Leonard Leibovici; Mical Paul
Journal:  Cochrane Database Syst Rev       Date:  2017-06-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.